Technical Analysis for RCE - Recce Ltd  

Grade Last Price % Change Price Change
grade B 0.215 -4.44% -0.010
RCE closed down 4.44 percent on Thursday, August 15, 2019, on 88 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Down
See historical RCE trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction -4.44%
Bollinger Band Squeeze Range Contraction -4.44%
BB Squeeze + Upper Band Touch Range Contraction -4.44%
Upper Bollinger Band Touch Strength -4.44%
Bollinger Band Squeeze Range Contraction -4.44%
BB Squeeze + Upper Band Touch Range Contraction -4.44%

Older signals for RCE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Interactive chart
Profile
Recce Limited is an Australia-based research-based pharmaceutical company. The Company is principally engaged in research and development of antibiotic drugs and anticancer drugs. The Company's antibiotics kill both susceptible bacteria and drug resistant super bugs throughout the world health danger arising from resistance to present-day antibiotics. The Company offers antibiotic drugs to treat the diseases caused by Sepsis, Helicobacter Pylori (H.Pylori), Escherichia coli (E.coli), Gonorrhea and Tuberculosis (TB). The Company offers anticancer drugs to treat various cancers, such as leukemia, prostate, lung, stomach, intestine, kidney and melanoma. The Company also offers polymer-antibiotics targeted for human use. The Company's Recce antibiotic kills all types of bacteria, including superbugs. Its subsidiaries include Recce (USA) LLP and Recce (UK) Limited.
Medicine Health Cancer Chemotherapy Diseases Pharmaceuticals Policy Cancers Bacteriology Veterinary Medicine Antibiotics Bacteria Leukemia Melanoma Antibiotic
Is RCE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
See more RCE news...
Indicators
Indicator Value
52 Week High 0.265
52 Week Low 0.13
Average Volume 104,131
200-Day Moving Average 0.1931
50-Day Moving Average 0.2153
20-Day Moving Average 0.2183
10-Day Moving Average 0.2195
Average True Range 0.0083
ADX 14.12
+DI 36.5749
-DI 25.043
Chandelier Exit (Long, 3 ATRs ) 0.2051
Chandelier Exit (Short, 3 ATRs ) 0.2349
Upper Bollinger Band 0.2279
Lower Bollinger Band 0.2087
Percent B (%b) 0.33
BandWidth 8.795236
MACD Line 0.0013
MACD Signal Line 0.001
MACD Histogram 0.0003
Fundamentals Value
Market Cap 16.4 Million
Num Shares 76.3 Million
EPS -0.04
Price-to-Earnings (P/E) Ratio -5.51
Price-to-Sales 177.95
Price-to-Book 6.21
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.223
Resistance 3 (R3) 0.223 0.222 0.221
Resistance 2 (R2) 0.222 0.220 0.221 0.221
Resistance 1 (R1) 0.218 0.219 0.218 0.218 0.220
Pivot Point 0.217 0.217 0.216 0.216 0.217
Support 1 (S1) 0.213 0.215 0.213 0.213 0.210
Support 2 (S2) 0.212 0.214 0.211 0.209
Support 3 (S3) 0.208 0.212 0.209
Support 4 (S4) 0.208